Quick Answer
BeOne Medicines Ltd. reported Net Income of $286.93 million for fiscal year 2025.
BeOne Medicines Ltd. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $286.93M | +144.5% |
| 2024 | -$644.79M | +26.9% |
| 2023 | -$881.71M | +56.0% |
| 2022 | -$2.00B | -37.5% |
| 2021 | -$1.46B | +10.3% |
| 2020 | -$1.62B | -71.3% |
| 2019 | -$948.63M | -40.8% |
| 2018 | -$673.77M | -623.7% |
| 2017 | -$93.11M | +21.9% |
| 2016 | -$119.22M | -108.8% |
| 2015 | -$57.10M | -212.4% |
| 2014 | -$18.28M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $124.84M | +202.9% | +32.4% |
| June 30, 2025 | $94.32M | +178.3% | +7326.8% |
| March 31, 2025 | $1.27M | +100.5% | +101.0% |
| September 30, 2024 | -$121.35M | -156.3% | -0.8% |
| June 30, 2024 | -$120.41M | +68.4% | +52.1% |
| March 31, 2024 | -$251.15M | +27.9% | -216.6% |
| September 30, 2023 | $215.41M | +138.6% | +156.5% |
| June 30, 2023 | -$381.14M | +32.6% | -9.4% |
- BeOne Medicines Ltd. showed an increase of +144.5% in Net Income compared to the prior fiscal year.
- Over the 2014–2025 period, BeOne Medicines Ltd.’s net income has grown by 1669.8% (from -$18.28 million to $286.93 million).
- The most recent figure is from BeOne Medicines Ltd.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: